Simple blood test could predict success of cancer immunotherapy
NCT ID NCT07018310
Summary
This study aims to develop a simple blood test to check if a patient's immune system is ready to fight blood cancer before starting immunotherapy. Researchers will analyze blood samples from 166 adults with blood cancers to measure how well their immune cells respond to stimulation. The goal is to create a test that could help doctors predict which patients will benefit most from immunotherapy treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assisitance Publique Hôpitaux de Marseille
Marseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.